BreezeBio

Autoimmune diseases and some cancers lack therapies that precisely target and durably correct underlying immune dysfunction rather than managing symptoms.

BreezeBio uses its NanoGalaxy® platform to precision-deliver genetic medicines to specific targets to modulate immune responses at their source.

Biopharma stakeholders and healthcare providers developing and delivering treatments for patients with autoimmune disease and oncology.